{"entryType":"UniProtKB reviewed (Swiss-Prot)","primaryAccession":"P04610","uniProtkbId":"TAT_HV1BR","entryAudit":{"firstPublicDate":"1987-08-13","lastAnnotationUpdateDate":"2023-11-08","lastSequenceUpdateDate":"1987-08-13","entryVersion":159,"sequenceVersion":1},"annotationScore":5.0,"organism":{"scientificName":"Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)","commonName":"HIV-1","taxonId":11686,"lineage":["Viruses","Riboviria","Pararnavirae","Artverviricota","Revtraviricetes","Ortervirales","Retroviridae","Orthoretrovirinae","Lentivirus","Human immunodeficiency virus 1"]},"organismHosts":[{"scientificName":"Homo sapiens","commonName":"Human","taxonId":9606}],"proteinExistence":"1: Evidence at protein level","proteinDescription":{"recommendedName":{"fullName":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Protein Tat"}},"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Transactivating regulatory protein"}}]},"genes":[{"geneName":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"tat"}}],"comments":[{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Nuclear transcriptional activator of viral gene expression, that is essential for viral transcription from the LTR promoter and replication. Acts as a sequence-specific molecular adapter, directing components of the cellular transcription machinery to the viral RNA to promote processive transcription elongation by the RNA polymerase II (RNA pol II) complex, thereby increasing the level of full-length transcripts. In the absence of Tat, the RNA Pol II generates short or non-processive transcripts that terminate at approximately 60 bp from the initiation site. Tat associates with the CCNT1/cyclin-T1 component of the P-TEFb complex (CDK9 and CCNT1), which promotes RNA chain elongation. This binding increases Tat's affinity for a hairpin structure at the 5'-end of all nascent viral mRNAs referred to as the transactivation responsive RNA element (TAR RNA) and allows Tat/P-TEFb complex to bind cooperatively to TAR RNA. The CDK9 component of P-TEFb and other Tat-activated kinases hyperphosphorylate the C-terminus of RNA Pol II that becomes stabilized and much more processive. Other factors such as HTATSF1/Tat-SF1, SUPT5H/SPT5, and HTATIP2 are also important for Tat's function. Besides its effect on RNA Pol II processivity, Tat induces chromatin remodeling of proviral genes by recruiting the histone acetyltransferases (HATs) CREBBP, EP300 and PCAF to the chromatin. This also contributes to the increase in proviral transcription rate, especially when the provirus integrates in transcriptionally silent region of the host genome. To ensure maximal activation of the LTR, Tat mediates nuclear translocation of NF-kappa-B by interacting with host RELA. Through its interaction with host TBP, Tat may also modulate transcription initiation. Tat can reactivate a latently infected cell by penetrating in it and transactivating its LTR promoter. In the cytoplasm, Tat is thought to act as a translational activator of HIV-1 mRNAs"}],"commentType":"FUNCTION"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Extracellular circulating Tat can be endocytosed by surrounding uninfected cells via the binding to several surface receptors such as CD26, CXCR4, heparan sulfate proteoglycans (HSPG) or LDLR. Neurons are rarely infected, but they internalize Tat via their LDLR. Through its interaction with nuclear HATs, Tat is potentially able to control the acetylation-dependent cellular gene expression. Modulates the expression of many cellular genes involved in cell survival, proliferation or in coding for cytokines or cytokine receptors. Tat plays a role in T-cell and neurons apoptosis. Tat induced neurotoxicity and apoptosis probably contribute to neuroAIDS. Circulating Tat also acts as a chemokine-like and/or growth factor-like molecule that binds to specific receptors on the surface of the cells, affecting many cellular pathways. In the vascular system, Tat binds to ITGAV/ITGB3 and ITGA5/ITGB1 integrins dimers at the surface of endothelial cells and competes with bFGF for heparin-binding sites, leading to an excess of soluble bFGF"}],"commentType":"FUNCTION"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Interacts with host CCNT1. Associates with the P-TEFb complex composed at least of Tat, P-TEFb (CDK9 and CCNT1), TAR RNA, RNA Pol II. Recruits the HATs CREBBP, TAF1/TFIID, EP300, PCAF and GCN5L2. Interacts with host KAT5/Tip60; this interaction targets the latter to degradation. Interacts with the host deacetylase SIRT1. Interacts with host capping enzyme RNGTT; this interaction stimulates RNGTT. Binds to host KDR, and to the host integrins ITGAV/ITGB3 and ITGA5/ITGB1. Interacts with host KPNB1/importin beta-1 without previous binding to KPNA1/importin alpha-1. Interacts with EIF2AK2. Interacts with host nucleosome assembly protein NAP1L1; this interaction may be required for the transport of Tat within the nucleus, since the two proteins interact at the nuclear rim. Interacts with host C1QBP/SF2P32; this interaction involves lysine-acetylated Tat. Interacts with the host chemokine receptors CCR2, CCR3 and CXCR4. Interacts with host DPP4/CD26; this interaction may trigger an anti-proliferative effect. Interacts with host LDLR. Interacts with the host extracellular matrix metalloproteinase MMP1. Interacts with host PRMT6; this interaction mediates Tat's methylation. Interacts with, and is ubiquitinated by MDM2/Hdm2. Interacts with host PSMC3 and HTATIP2. Interacts with STAB1; this interaction may overcome SATB1-mediated repression of IL2 and IL2RA (interleukin) in T cells by binding to the same domain than HDAC1. Interacts (when acetylated) with human CDK13, thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef.Interacts with host TBP; this interaction modulates the activity of transcriptional pre-initiation complex. Interacts with host RELA. Interacts with host PLSCR1; this interaction negatively regulates Tat transactivation activity by altering its subcellular distribution"}],"commentType":"SUBUNIT"},{"commentType":"INTERACTION","interactions":[{"interactantOne":{"uniProtKBAccession":"P04610","intActId":"EBI-7845069"},"interactantTwo":{"uniProtKBAccession":"O60563","geneName":"CCNT1","intActId":"EBI-2479671"},"numberOfExperiments":2,"organismDiffer":true},{"interactantOne":{"uniProtKBAccession":"P04610","intActId":"EBI-7845069"},"interactantTwo":{"uniProtKBAccession":"Q9UBN7","geneName":"HDAC6","intActId":"EBI-301697"},"numberOfExperiments":10,"organismDiffer":true}]},{"commentType":"SUBCELLULAR LOCATION","note":{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Probably localizes to both nuclear and nucleolar compartments. Nuclear localization is mediated through the interaction of the nuclear localization signal with importin KPNB1. Secretion occurs through a Golgi-independent pathway. Tat is released from infected cells to the extracellular space where it remains associated to the cell membrane, or is secreted into the cerebrospinal fluid and sera. Extracellular Tat can be endocytosed by surrounding uninfected cells via binding to several receptors depending on the cell type"}]},"subcellularLocations":[{"location":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Host nucleus, host nucleolus","id":"SL-0412"}},{"location":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Host cytoplasm","id":"SL-0381"}},{"location":{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Secreted","id":"SL-0243"}}]},{"commentType":"ALTERNATIVE PRODUCTS","events":["Alternative splicing"],"isoforms":[{"name":{"value":"Long"},"isoformIds":["P04610-1"],"isoformSequenceStatus":"Displayed"},{"name":{"value":"Short"},"isoformIds":["P04610-2"],"sequenceIds":["VSP_022299"],"isoformSequenceStatus":"Described"}]},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"10397733"}],"value":"The cell attachment site mediates the interaction with ITGAV/ITGB3 and ITGA5/ITGB1 integrins, leading to vascular cell migration and invasion. This interaction also provides endothelial cells with the adhesion signal they require to grow in response to mitogens"}],"commentType":"DOMAIN"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"The Cys-rich region may bind 2 zinc ions. This region is involved in binding to KAT5"}],"commentType":"DOMAIN"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"The transactivation domain mediates the interaction with CCNT1, GCN5L2, and MDM2"}],"commentType":"DOMAIN"},{"texts":[{"value":"The Arg-rich RNA-binding region binds the TAR RNA. This region also mediates the nuclear localization through direct binding to KPNB1 and is involved in Tat's transfer across cell membranes (protein transduction). The same region is required for the interaction with EP300, PCAF, EIF2AK2 and KDR"}],"commentType":"DOMAIN"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Asymmetrical arginine methylation by host PRMT6 seems to diminish the transactivation capacity of Tat and affects the interaction with host CCNT1"}],"commentType":"PTM"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Acetylation by EP300, CREBBP, GCN5L2/GCN5 and PCAF regulates the transactivation activity of Tat. EP300-mediated acetylation of Lys-50 promotes dissociation of Tat from the TAR RNA through the competitive binding to PCAF's bromodomain. In addition, the non-acetylated Tat's N-terminus can also interact with PCAF. PCAF-mediated acetylation of Lys-28 enhances Tat's binding to CCNT1. Lys-50 is deacetylated by SIRT1"}],"commentType":"PTM"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"12883554"}],"value":"Polyubiquitination by host MDM2 does not target Tat to degradation, but activates its transactivation function and fosters interaction with CCNT1 and TAR RNA"}],"commentType":"PTM"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Phosphorylated by EIF2AK2 on serine and threonine residues adjacent to the basic region important for TAR RNA binding and function. Phosphorylation of Tat by EIF2AK2 is dependent on the prior activation of EIF2AK2 by dsRNA"}],"commentType":"PTM"},{"texts":[{"value":"The infectious clone pNL4-3 is a chimeric provirus that consists of DNA from HIV isolates NY5 (5' half) and BRU (3' half)"}],"commentType":"MISCELLANEOUS"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"This truncated variant has a premature stop codon. It may have arose as a consequence of tissue culture passaging"}],"commentType":"MISCELLANEOUS"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"HIV-1 lineages are divided in three main groups, M (for Major), O (for Outlier), and N (for New, or Non-M, Non-O). The vast majority of strains found worldwide belong to the group M. Group O seems to be endemic to and largely confined to Cameroon and neighboring countries in West Central Africa, where these viruses represent a small minority of HIV-1 strains. The group N is represented by a limited number of isolates from Cameroonian persons. The group M is further subdivided in 9 clades or subtypes (A to D, F to H, J and K)"}],"commentType":"MISCELLANEOUS"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Expressed in the late stage of the infection cycle, when unspliced viral RNAs are exported to the cytoplasm by the viral Rev protein"}],"commentType":"MISCELLANEOUS","molecule":"Isoform Short"},{"texts":[{"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"value":"Belongs to the lentiviruses Tat family"}],"commentType":"SIMILARITY"}],"features":[{"type":"Chain","location":{"start":{"value":1,"modifier":"EXACT"},"end":{"value":86,"modifier":"EXACT"}},"description":"Protein Tat","featureId":"PRO_0000085346"},{"type":"Region","location":{"start":{"value":1,"modifier":"EXACT"},"end":{"value":48,"modifier":"EXACT"}},"description":"Transactivation","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}]},{"type":"Region","location":{"start":{"value":1,"modifier":"EXACT"},"end":{"value":24,"modifier":"EXACT"}},"description":"Interaction with human CREBBP","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}]},{"type":"Region","location":{"start":{"value":1,"modifier":"EXACT"},"end":{"value":20,"modifier":"EXACT"}},"description":"Disordered","evidences":[{"evidenceCode":"ECO:0000256","source":"SAM","id":"MobiDB-lite"}]},{"type":"Region","location":{"start":{"value":22,"modifier":"EXACT"},"end":{"value":37,"modifier":"EXACT"}},"description":"Cysteine-rich","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}]},{"type":"Region","location":{"start":{"value":38,"modifier":"EXACT"},"end":{"value":48,"modifier":"EXACT"}},"description":"Core","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}]},{"type":"Region","location":{"start":{"value":47,"modifier":"EXACT"},"end":{"value":86,"modifier":"EXACT"}},"description":"Disordered","evidences":[{"evidenceCode":"ECO:0000256","source":"SAM","id":"MobiDB-lite"}]},{"type":"Region","location":{"start":{"value":49,"modifier":"EXACT"},"end":{"value":86,"modifier":"EXACT"}},"description":"Interaction with the host capping enzyme RNGTT","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}]},{"type":"Motif","location":{"start":{"value":49,"modifier":"EXACT"},"end":{"value":57,"modifier":"EXACT"}},"description":"Nuclear localization signal, RNA-binding (TAR), and protein transduction","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"9891055"}]},{"type":"Motif","location":{"start":{"value":78,"modifier":"EXACT"},"end":{"value":80,"modifier":"EXACT"}},"description":"Cell attachment site","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}]},{"type":"Compositional bias","location":{"start":{"value":60,"modifier":"EXACT"},"end":{"value":79,"modifier":"EXACT"}},"description":"Polar residues","evidences":[{"evidenceCode":"ECO:0000256","source":"SAM","id":"MobiDB-lite"}]},{"type":"Binding site","location":{"start":{"value":22,"modifier":"EXACT"},"end":{"value":22,"modifier":"EXACT"}},"description":"","featureCrossReferences":[{"database":"ChEBI","id":"CHEBI:29105"}],"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"ligand":{"name":"Zn(2+)","id":"ChEBI:CHEBI:29105","label":"1"}},{"type":"Binding site","location":{"start":{"value":25,"modifier":"EXACT"},"end":{"value":25,"modifier":"EXACT"}},"description":"","featureCrossReferences":[{"database":"ChEBI","id":"CHEBI:29105"}],"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"ligand":{"name":"Zn(2+)","id":"ChEBI:CHEBI:29105","label":"2"}},{"type":"Binding site","location":{"start":{"value":27,"modifier":"EXACT"},"end":{"value":27,"modifier":"EXACT"}},"description":"","featureCrossReferences":[{"database":"ChEBI","id":"CHEBI:29105"}],"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"ligand":{"name":"Zn(2+)","id":"ChEBI:CHEBI:29105","label":"2"}},{"type":"Binding site","location":{"start":{"value":30,"modifier":"EXACT"},"end":{"value":30,"modifier":"EXACT"}},"description":"","featureCrossReferences":[{"database":"ChEBI","id":"CHEBI:29105"}],"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"ligand":{"name":"Zn(2+)","id":"ChEBI:CHEBI:29105","label":"2"}},{"type":"Binding site","location":{"start":{"value":33,"modifier":"EXACT"},"end":{"value":33,"modifier":"EXACT"}},"description":"","featureCrossReferences":[{"database":"ChEBI","id":"CHEBI:29105"}],"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"ligand":{"name":"Zn(2+)","id":"ChEBI:CHEBI:29105","label":"1"}},{"type":"Binding site","location":{"start":{"value":34,"modifier":"EXACT"},"end":{"value":34,"modifier":"EXACT"}},"description":"","featureCrossReferences":[{"database":"ChEBI","id":"CHEBI:29105"}],"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"ligand":{"name":"Zn(2+)","id":"ChEBI:CHEBI:29105","label":"1"}},{"type":"Binding site","location":{"start":{"value":37,"modifier":"EXACT"},"end":{"value":37,"modifier":"EXACT"}},"description":"","featureCrossReferences":[{"database":"ChEBI","id":"CHEBI:29105"}],"evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}],"ligand":{"name":"Zn(2+)","id":"ChEBI:CHEBI:29105","label":"1"}},{"type":"Site","location":{"start":{"value":11,"modifier":"EXACT"},"end":{"value":11,"modifier":"EXACT"}},"description":"Essential for Tat translocation through the endosomal membrane","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}]},{"type":"Modified residue","location":{"start":{"value":28,"modifier":"EXACT"},"end":{"value":28,"modifier":"EXACT"}},"description":"N6-acetyllysine; by host PCAF","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"10545121"}]},{"type":"Modified residue","location":{"start":{"value":50,"modifier":"EXACT"},"end":{"value":50,"modifier":"EXACT"}},"description":"N6-acetyllysine; by host EP300 and GCN5L2","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"10545121"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11080476"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11384967"}]},{"type":"Modified residue","location":{"start":{"value":51,"modifier":"EXACT"},"end":{"value":51,"modifier":"EXACT"}},"description":"N6-acetyllysine; by host EP300 and GCN5L2","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11080476"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11384967"}]},{"type":"Modified residue","location":{"start":{"value":52,"modifier":"EXACT"},"end":{"value":52,"modifier":"EXACT"}},"description":"Asymmetric dimethylarginine; by host PRMT6","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}]},{"type":"Modified residue","location":{"start":{"value":53,"modifier":"EXACT"},"end":{"value":53,"modifier":"EXACT"}},"description":"Asymmetric dimethylarginine; by host PRMT6","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"}]},{"type":"Cross-link","location":{"start":{"value":71,"modifier":"EXACT"},"end":{"value":71,"modifier":"EXACT"}},"description":"Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)","evidences":[{"evidenceCode":"ECO:0000255","source":"HAMAP-Rule","id":"MF_04079"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"12883554"}]},{"type":"Alternative sequence","location":{"start":{"value":73,"modifier":"EXACT"},"end":{"value":86,"modifier":"EXACT"}},"description":"in isoform Short","featureId":"VSP_022299","alternativeSequence":{}},{"type":"Natural variant","location":{"start":{"value":24,"modifier":"EXACT"},"end":{"value":24,"modifier":"EXACT"}},"description":"in strain: Clone pNL4-3","featureId":"","alternativeSequence":{"originalSequence":"T","alternativeSequences":["N"]}},{"type":"Natural variant","location":{"start":{"value":39,"modifier":"EXACT"},"end":{"value":39,"modifier":"EXACT"}},"description":"in strain: Clone pNL4-3","featureId":"","alternativeSequence":{"originalSequence":"T","alternativeSequences":["M"]}},{"type":"Natural variant","location":{"start":{"value":58,"modifier":"EXACT"},"end":{"value":61,"modifier":"EXACT"}},"description":"in strain: Clone pNL4-3","featureId":"","alternativeSequence":{"originalSequence":"PPQG","alternativeSequences":["AHQN"]}},{"type":"Natural variant","location":{"start":{"value":67,"modifier":"EXACT"},"end":{"value":67,"modifier":"EXACT"}},"description":"in strain: Clone pNL4-3","featureId":"","alternativeSequence":{"originalSequence":"V","alternativeSequences":["A"]}},{"type":"Natural variant","location":{"start":{"value":77,"modifier":"EXACT"},"end":{"value":77,"modifier":"EXACT"}},"description":"in strain: Clone pNL4-3","featureId":"","alternativeSequence":{"originalSequence":"P","alternativeSequences":["S"]}},{"type":"Mutagenesis","location":{"start":{"value":28,"modifier":"EXACT"},"end":{"value":28,"modifier":"EXACT"}},"description":"Strong decrease in Tat transactivation.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"10545121"}],"alternativeSequence":{"originalSequence":"K","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":50,"modifier":"EXACT"},"end":{"value":50,"modifier":"EXACT"}},"description":"Strong decrease in Tat transactivation.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"10545121"},{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11080476"}],"alternativeSequence":{"originalSequence":"K","alternativeSequences":["A"]}},{"type":"Mutagenesis","location":{"start":{"value":51,"modifier":"EXACT"},"end":{"value":51,"modifier":"EXACT"}},"description":"Strong decrease in Tat transactivation.","evidences":[{"evidenceCode":"ECO:0000269","source":"PubMed","id":"11080476"}],"alternativeSequence":{"originalSequence":"K","alternativeSequences":["A"]}},{"type":"Beta strand","location":{"start":{"value":16,"modifier":"EXACT"},"end":{"value":18,"modifier":"EXACT"}},"description":"","evidences":[{"evidenceCode":"ECO:0007829","source":"PDB","id":"1JFW"}]},{"type":"Beta strand","location":{"start":{"value":20,"modifier":"EXACT"},"end":{"value":23,"modifier":"EXACT"}},"description":"","evidences":[{"evidenceCode":"ECO:0007829","source":"PDB","id":"1JFW"}]},{"type":"Turn","location":{"start":{"value":26,"modifier":"EXACT"},"end":{"value":29,"modifier":"EXACT"}},"description":"","evidences":[{"evidenceCode":"ECO:0007829","source":"PDB","id":"1JFW"}]},{"type":"Beta strand","location":{"start":{"value":32,"modifier":"EXACT"},"end":{"value":35,"modifier":"EXACT"}},"description":"","evidences":[{"evidenceCode":"ECO:0007829","source":"PDB","id":"1JFW"}]},{"type":"Turn","location":{"start":{"value":39,"modifier":"EXACT"},"end":{"value":41,"modifier":"EXACT"}},"description":"","evidences":[{"evidenceCode":"ECO:0007829","source":"PDB","id":"1JFW"}]},{"type":"Beta strand","location":{"start":{"value":42,"modifier":"EXACT"},"end":{"value":44,"modifier":"EXACT"}},"description":"","evidences":[{"evidenceCode":"ECO:0007829","source":"PDB","id":"1JFW"}]},{"type":"Beta strand","location":{"start":{"value":47,"modifier":"EXACT"},"end":{"value":50,"modifier":"EXACT"}},"description":"","evidences":[{"evidenceCode":"ECO:0007829","source":"PDB","id":"1JFW"}]},{"type":"Beta strand","location":{"start":{"value":60,"modifier":"EXACT"},"end":{"value":62,"modifier":"EXACT"}},"description":"","evidences":[{"evidenceCode":"ECO:0007829","source":"PDB","id":"1JFW"}]},{"type":"Beta strand","location":{"start":{"value":69,"modifier":"EXACT"},"end":{"value":73,"modifier":"EXACT"}},"description":"","evidences":[{"evidenceCode":"ECO:0007829","source":"PDB","id":"1JFW"}]},{"type":"Beta strand","location":{"start":{"value":78,"modifier":"EXACT"},"end":{"value":82,"modifier":"EXACT"}},"description":"","evidences":[{"evidenceCode":"ECO:0007829","source":"PDB","id":"1JFW"}]}],"keywords":[{"id":"KW-0002","category":"Technical term","name":"3D-structure"},{"id":"KW-0007","category":"PTM","name":"Acetylation"},{"id":"KW-0010","category":"Molecular function","name":"Activator"},{"id":"KW-0014","category":"Disease","name":"AIDS"},{"id":"KW-0025","category":"Coding sequence diversity","name":"Alternative splicing"},{"id":"KW-0053","category":"Biological process","name":"Apoptosis"},{"id":"KW-1035","category":"Cellular component","name":"Host cytoplasm"},{"id":"KW-1048","category":"Cellular component","name":"Host nucleus"},{"id":"KW-0945","category":"Biological process","name":"Host-virus interaction"},{"id":"KW-1090","category":"Biological process","name":"Inhibition of host innate immune response by virus"},{"id":"KW-1114","category":"Biological process","name":"Inhibition of host interferon signaling pathway by virus"},{"id":"KW-1017","category":"PTM","name":"Isopeptide bond"},{"id":"KW-0479","category":"Ligand","name":"Metal-binding"},{"id":"KW-0488","category":"PTM","name":"Methylation"},{"id":"KW-1122","category":"Biological process","name":"Modulation of host chromatin by virus"},{"id":"KW-1126","category":"Biological process","name":"Modulation of host PP1 activity by virus"},{"id":"KW-0597","category":"PTM","name":"Phosphoprotein"},{"id":"KW-1185","category":"Technical term","name":"Reference proteome"},{"id":"KW-0694","category":"Molecular function","name":"RNA-binding"},{"id":"KW-0964","category":"Cellular component","name":"Secreted"},{"id":"KW-0804","category":"Biological process","name":"Transcription"},{"id":"KW-0805","category":"Biological process","name":"Transcription regulation"},{"id":"KW-0832","category":"PTM","name":"Ubl conjugation"},{"id":"KW-0899","category":"Biological process","name":"Viral immunoevasion"},{"id":"KW-0862","category":"Ligand","name":"Zinc"}],"references":[{"citation":{"id":"2981635","citationType":"journal article","authors":["Wain-Hobson S.","Sonigo P.","Danos O.","Cole S.","Alizon M."],"citationCrossReferences":[{"database":"PubMed","id":"2981635"},{"database":"DOI","id":"10.1016/0092-8674(85)90303-4"}],"title":"Nucleotide sequence of the AIDS virus, LAV.","publicationDate":"1985","journal":"Cell","firstPage":"9","lastPage":"17","volume":"40"},"referencePositions":["NUCLEOTIDE SEQUENCE [GENOMIC RNA]"]},{"citation":{"id":"CI-CTGV5HHOIGRK2","citationType":"submission","authors":["Buckler C.E.","Buckler-White A.J.","Willey R.L.","McCoy J."],"publicationDate":"JUN-1988","submissionDatabase":"EMBL/GenBank/DDBJ databases"},"referencePositions":["NUCLEOTIDE SEQUENCE [GENOMIC RNA]"],"referenceComments":[{"value":"Clone pNL4-3","type":"STRAIN"}]},{"citation":{"id":"2194290","citationType":"journal article","authors":["Nelbock P.","Dillion P.J.","Perkins A.","Rosen C.A."],"citationCrossReferences":[{"database":"PubMed","id":"2194290"},{"database":"DOI","id":"10.1126/science.2194290"}],"title":"A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator.","publicationDate":"1990","journal":"Science","firstPage":"1650","lastPage":"1653","volume":"248"},"referencePositions":["INTERACTION WITH HUMAN PSMC3"]},{"citation":{"id":"8121496","citationType":"journal article","authors":["Kashanchi F.","Piras G.","Radonovich M.F.","Duvall J.F.","Fattaey A.","Chiang C.M.","Roeder R.G.","Brady J.N."],"citationCrossReferences":[{"database":"PubMed","id":"8121496"},{"database":"DOI","id":"10.1038/367295a0"}],"title":"Direct interaction of human TFIID with the HIV-1 transactivator tat.","publicationDate":"1994","journal":"Nature","firstPage":"295","lastPage":"299","volume":"367"},"referencePositions":["INTERACTION WITH HUMAN TBP"]},{"citation":{"id":"7912830","citationType":"journal article","authors":["Gutheil W.G.","Subramanyam M.","Flentke G.R.","Sanford D.G.","Munoz E.","Huber B.T.","Bachovchin W.W."],"citationCrossReferences":[{"database":"PubMed","id":"7912830"},{"database":"DOI","id":"10.1073/pnas.91.14.6594"}],"title":"Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.","publicationDate":"1994","journal":"Proc. Natl. Acad. Sci. U.S.A.","firstPage":"6594","lastPage":"6598","volume":"91"},"referencePositions":["INTERACTION WITH HUMAN DPP4"]},{"citation":{"id":"7638159","citationType":"journal article","authors":["Wu-Baer F.","Sigman D.","Gaynor R.B."],"citationCrossReferences":[{"database":"PubMed","id":"7638159"},{"database":"DOI","id":"10.1073/pnas.92.16.7153"}],"title":"Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.","publicationDate":"1995","journal":"Proc. Natl. Acad. Sci. U.S.A.","firstPage":"7153","lastPage":"7157","volume":"92"},"referencePositions":["FUNCTION"]},{"citation":{"id":"7608968","citationType":"journal article","authors":["Veschambre P.","Simard P.","Jalinot P."],"citationCrossReferences":[{"database":"PubMed","id":"7608968"},{"database":"DOI","id":"10.1006/jmbi.1995.0368"}],"title":"Evidence for functional interaction between the HIV-1 Tat transactivator and the TATA box binding protein in vivo.","publicationDate":"1995","journal":"J. Mol. Biol.","firstPage":"169","lastPage":"180","volume":"250"},"referencePositions":["INTERACTION WITH HUMAN TBP"]},{"citation":{"id":"8934526","citationType":"journal article","authors":["Parada C.A.","Roeder R.G."],"citationCrossReferences":[{"database":"PubMed","id":"8934526"},{"database":"DOI","id":"10.1038/384375a0"}],"title":"Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.","publicationDate":"1996","journal":"Nature","firstPage":"375","lastPage":"378","volume":"384"},"referencePositions":["FUNCTION"]},{"citation":{"id":"8607265","citationType":"journal article","authors":["Kamine J.","Elangovan B.","Subramanian T.","Coleman D.","Chinnadurai G."],"citationCrossReferences":[{"database":"PubMed","id":"8607265"},{"database":"DOI","id":"10.1006/viro.1996.0071"}],"title":"Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator.","publicationDate":"1996","journal":"Virology","firstPage":"357","lastPage":"366","volume":"216"},"referencePositions":["INTERACTION WITH HUMAN KAT5"]},{"citation":{"id":"8878561","citationType":"journal article","authors":["Huang H.-W.","Wang K.-T."],"citationCrossReferences":[{"database":"PubMed","id":"8878561"},{"database":"DOI","id":"10.1006/bbrc.1996.1554"}],"title":"Structural characterization of the metal binding site in the cysteine-rich region of HIV-1 Tat protein.","publicationDate":"1996","journal":"Biochem. Biophys. Res. Commun.","firstPage":"615","lastPage":"621","volume":"227"},"referencePositions":["CYS-RICH REGION","ZINC-BINDING","IDENTIFICATION BY MASS SPECTROMETRY"]},{"citation":{"id":"8676466","citationType":"journal article","authors":["Demarchi F.","d'Adda di Fagagna F.","Falaschi A.","Giacca M."],"citationCrossReferences":[{"database":"PubMed","id":"8676466"},{"database":"DOI","id":"10.1128/jvi.70.7.4427-4437.1996"}],"title":"Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.","publicationDate":"1996","journal":"J. Virol.","firstPage":"4427","lastPage":"4437","volume":"70"},"referencePositions":["FUNCTION"]},{"citation":{"id":"9649438","citationType":"journal article","authors":["Zhou Q.","Chen D.","Pierstorff E.","Luo K."],"citationCrossReferences":[{"database":"PubMed","id":"9649438"},{"database":"DOI","id":"10.1093/emboj/17.13.3681"}],"title":"Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.","publicationDate":"1998","journal":"EMBO J.","firstPage":"3681","lastPage":"3691","volume":"17"},"referencePositions":["IDENTIFICATION IN A COMPLEX WITH P-TEFB; TAR RNA AND RNA POL II"]},{"citation":{"id":"9789057","citationType":"journal article","authors":["Albini A.","Ferrini S.","Benelli R.","Sforzini S.","Giunciuglio D.","Aluigi M.G.","Proudfoot A.E.I.","Alouani S.","Wells T.N.C.","Mariani G.","Rabin R.L.","Farber J.M.","Noonan D.M."],"citationCrossReferences":[{"database":"PubMed","id":"9789057"},{"database":"DOI","id":"10.1073/pnas.95.22.13153"}],"title":"HIV-1 Tat protein mimicry of chemokines.","publicationDate":"1998","journal":"Proc. Natl. Acad. Sci. U.S.A.","firstPage":"13153","lastPage":"13158","volume":"95"},"referencePositions":["INTERACTION WITH HUMAN CCR2 AND CCR3"]},{"citation":{"id":"9482853","citationType":"journal article","authors":["Xiao H.","Tao Y.","Greenblatt J.","Roeder R.G."],"citationCrossReferences":[{"database":"PubMed","id":"9482853"},{"database":"DOI","id":"10.1073/pnas.95.5.2146"}],"title":"A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription.","publicationDate":"1998","journal":"Proc. Natl. Acad. Sci. U.S.A.","firstPage":"2146","lastPage":"2151","volume":"95"},"referencePositions":["INTERACTION WITH HUMAN HTATIP2"]},{"citation":{"id":"10329125","citationType":"journal article","authors":["Ivanov D.","Kwak Y.T.","Nee E.","Guo J.","Garcia-Martinez L.F.","Gaynor R.B."],"citationCrossReferences":[{"database":"PubMed","id":"10329125"},{"database":"DOI","id":"10.1006/jmbi.1999.2663"}],"title":"Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation.","publicationDate":"1999","journal":"J. Mol. Biol.","firstPage":"41","lastPage":"56","volume":"288"},"referencePositions":["FUNCTION","INTERACTION WITH HUMAN CCNT1","IDENTIFICATION IN A COMPLEX WITH CCNT1; CDK9 AND TAR RNA"]},{"citation":{"id":"9891055","citationType":"journal article","authors":["Truant R.","Cullen B.R."],"citationCrossReferences":[{"database":"PubMed","id":"9891055"},{"database":"DOI","id":"10.1128/mcb.19.2.1210"}],"title":"The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals.","publicationDate":"1999","journal":"Mol. Cell. Biol.","firstPage":"1210","lastPage":"1217","volume":"19"},"referencePositions":["NUCLEAR LOCALIZATION SIGNAL","INTERACTION WITH KPNB1"]},{"citation":{"id":"10400814","citationType":"journal article","authors":["Demarchi F.","Gutierrez M.I.","Giacca M."],"citationCrossReferences":[{"database":"PubMed","id":"10400814"},{"database":"DOI","id":"10.1128/jvi.73.8.7080-7086.1999"}],"title":"Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR.","publicationDate":"1999","journal":"J. Virol.","firstPage":"7080","lastPage":"7086","volume":"73"},"referencePositions":["FUNCTION"]},{"citation":{"id":"10397733","citationType":"journal article","authors":["Barillari G.","Sgadari C.","Fiorelli V.","Samaniego F.","Colombini S.","Manzari V.","Modesti A.","Nair B.C.","Cafaro A.","Stuerzl M.","Ensoli B."],"citationCrossReferences":[{"database":"PubMed","id":"10397733"}],"title":"The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor.","publicationDate":"1999","journal":"Blood","firstPage":"663","lastPage":"672","volume":"94"},"referencePositions":["INTERACTION WITH HUMAN ITGAV/ITGB3 AND ITGA5/ITGB1 INTEGRINS"]},{"citation":{"id":"10364329","citationType":"journal article","authors":["Bieniasz P.D.","Grdina T.A.","Bogerd H.P.","Cullen B.R."],"citationCrossReferences":[{"database":"PubMed","id":"10364329"},{"database":"DOI","id":"10.1128/jvi.73.7.5777-5786.1999"}],"title":"Analysis of the effect of natural sequence variation in Tat and in cyclin T on the formation and RNA binding properties of Tat-cyclin T complexes.","publicationDate":"1999","journal":"J. Virol.","firstPage":"5777","lastPage":"5786","volume":"73"},"referencePositions":["INTERACTION WITH HUMAN CCNT1"]},{"citation":{"id":"10545121","citationType":"journal article","authors":["Kiernan R.E.","Vanhulle C.","Schiltz L.","Adam E.","Xiao H.","Maudoux F.","Calomme C.","Burny A.","Nakatani Y.","Jeang K.-T.","Benkirane M.","Van Lint C."],"citationCrossReferences":[{"database":"PubMed","id":"10545121"},{"database":"DOI","id":"10.1093/emboj/18.21.6106"}],"title":"HIV-1 tat transcriptional activity is regulated by acetylation.","publicationDate":"1999","journal":"EMBO J.","firstPage":"6106","lastPage":"6118","volume":"18"},"referencePositions":["ACETYLATION AT LYS-50 BY EP300","ACETYLATION AT LYS-28 BY PCAF","MUTAGENESIS OF LYS-28 AND LYS-50"]},{"citation":{"id":"11027346","citationType":"journal article","authors":["Xiao H.","Neuveut C.","Tiffany H.L.","Benkirane M.","Rich E.A.","Murphy P.M.","Jeang K.-T."],"citationCrossReferences":[{"database":"PubMed","id":"11027346"},{"database":"DOI","id":"10.1073/pnas.97.21.11466"}],"title":"Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1.","publicationDate":"2000","journal":"Proc. Natl. Acad. Sci. U.S.A.","firstPage":"11466","lastPage":"11471","volume":"97"},"referencePositions":["INTERACTION WITH HUMAN CXCR4"],"referenceComments":[{"value":"Clone pNL4-3","type":"STRAIN"}]},{"citation":{"id":"10590123","citationType":"journal article","authors":["Mitola S.","Soldi R.","Zanon I.","Barra L.","Gutierrez M.I.","Berkhout B.","Giacca M.","Bussolino F."],"citationCrossReferences":[{"database":"PubMed","id":"10590123"},{"database":"DOI","id":"10.1128/jvi.74.1.344-353.2000"}],"title":"Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells.","publicationDate":"2000","journal":"J. Virol.","firstPage":"344","lastPage":"353","volume":"74"},"referencePositions":["INTERACTION WITH HUMAN KDR; ITGAV AND ITGB1"]},{"citation":{"id":"11080476","citationType":"journal article","authors":["Deng L.","de la Fuente C.","Fu P.","Wang L.","Donnelly R.","Wade J.D.","Lambert P.","Li H.","Lee C.-G.","Kashanchi F."],"citationCrossReferences":[{"database":"PubMed","id":"11080476"},{"database":"DOI","id":"10.1006/viro.2000.0593"}],"title":"Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.","publicationDate":"2000","journal":"Virology","firstPage":"278","lastPage":"295","volume":"277"},"referencePositions":["ACETYLATION AT LYS-50 AND LYS-51 BY EP300","MUTAGENESIS OF LYS-50 AND LYS-51"]},{"citation":{"id":"10958691","citationType":"journal article","authors":["Garber M.E.","Mayall T.P.","Suess E.M.","Meisenhelder J.","Thompson N.E.","Jones K.A."],"citationCrossReferences":[{"database":"PubMed","id":"10958691"},{"database":"DOI","id":"10.1128/mcb.20.18.6958-6969.2000"}],"title":"CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.","publicationDate":"2000","journal":"Mol. Cell. Biol.","firstPage":"6958","lastPage":"6969","volume":"20"},"referencePositions":["FUNCTION"]},{"citation":{"id":"11278368","citationType":"journal article","authors":["Chiu Y.-L.","Coronel E.","Ho C.K.","Shuman S.","Rana T.M."],"citationCrossReferences":[{"database":"PubMed","id":"11278368"},{"database":"DOI","id":"10.1074/jbc.m007901200"}],"title":"HIV-1 Tat protein interacts with mammalian capping enzyme and stimulates capping of TAR RNA.","publicationDate":"2001","journal":"J. Biol. Chem.","firstPage":"12959","lastPage":"12966","volume":"276"},"referencePositions":["INTERACTION WITH HOST RNGTT"]},{"citation":{"id":"11024024","citationType":"journal article","authors":["Tyagi M.","Rusnati M.","Presta M.","Giacca M."],"citationCrossReferences":[{"database":"PubMed","id":"11024024"},{"database":"DOI","id":"10.1074/jbc.m006701200"}],"title":"Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans.","publicationDate":"2001","journal":"J. Biol. Chem.","firstPage":"3254","lastPage":"3261","volume":"276"},"referencePositions":["INTERACTION WITH HEPARAN SULFATE PROTEOGLYCANS"]},{"citation":{"id":"11384967","citationType":"journal article","authors":["Col E.","Caron C.","Seigneurin-Berny D.","Gracia J.","Favier A.","Khochbin S."],"citationCrossReferences":[{"database":"PubMed","id":"11384967"},{"database":"DOI","id":"10.1074/jbc.m101385200"}],"title":"The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat.","publicationDate":"2001","journal":"J. Biol. Chem.","firstPage":"28179","lastPage":"28184","volume":"276"},"referencePositions":["INTERACTION WITH HUMAN GCN5L2","ACETYLATION AT LYS-50 AND LYS-51 BY HUMAN GCN5L2"]},{"citation":{"id":"12052871","citationType":"journal article","authors":["Kim Y.K.","Bourgeois C.F.","Isel C.","Churcher M.J.","Karn J."],"citationCrossReferences":[{"database":"PubMed","id":"12052871"},{"database":"DOI","id":"10.1128/mcb.22.13.4622-4637.2002"}],"title":"Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation.","publicationDate":"2002","journal":"Mol. Cell. Biol.","firstPage":"4622","lastPage":"4637","volume":"22"},"referencePositions":["FUNCTION"]},{"citation":{"id":"12486002","citationType":"journal article","authors":["Bres V.","Tagami H.","Peloponese J.-M.","Loret E.","Jeang K.-T.","Nakatani Y.","Emiliani S.","Benkirane M.","Kiernan R.E."],"citationCrossReferences":[{"database":"PubMed","id":"12486002"},{"database":"DOI","id":"10.1093/emboj/cdf669"}],"title":"Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF.","publicationDate":"2002","journal":"EMBO J.","firstPage":"6811","lastPage":"6819","volume":"21"},"referencePositions":["INTERACTION WITH HUMAN PCAF"]},{"citation":{"id":"12154097","citationType":"journal article","authors":["Col E.","Gilquin B.","Caron C.","Khochbin S."],"citationCrossReferences":[{"database":"PubMed","id":"12154097"},{"database":"DOI","id":"10.1074/jbc.m206694200"}],"title":"Tat-controlled protein acetylation.","publicationDate":"2002","journal":"J. Biol. Chem.","firstPage":"37955","lastPage":"37960","volume":"277"},"referencePositions":["FUNCTION"]},{"citation":{"id":"12032084","citationType":"journal article","authors":["Dorr A.","Kiermer V.","Pedal A.","Rackwitz H.R.","Henklein P.","Schubert U.","Zhou M.-M.","Verdin E.","Ott M."],"citationCrossReferences":[{"database":"PubMed","id":"12032084"},{"database":"DOI","id":"10.1093/emboj/21.11.2715"}],"title":"Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain.","publicationDate":"2002","journal":"EMBO J.","firstPage":"2715","lastPage":"2723","volume":"21"},"referencePositions":["INTERACTION WITH HUMAN PCAF BROMODOMAIN"]},{"citation":{"id":"12883554","citationType":"journal article","authors":["Bres V.","Kiernan R.E.","Linares L.K.","Chable-Bessia C.","Plechakova O.","Treand C.","Emiliani S.","Peloponese J.-M.","Jeang K.-T.","Coux O.","Scheffner M.","Benkirane M."],"citationCrossReferences":[{"database":"PubMed","id":"12883554"},{"database":"DOI","id":"10.1038/ncb1023"}],"title":"A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter.","publicationDate":"2003","journal":"Nat. Cell Biol.","firstPage":"754","lastPage":"761","volume":"5"},"referencePositions":["UBIQUITINATION AT LYS-71 BY HUMAN MDM2","INTERACTION WITH HUMAN MDM2"],"referenceComments":[{"value":"Clone pNL4-3","type":"STRAIN"}]},{"citation":{"id":"15117453","citationType":"journal article","authors":["Misumi S.","Takamune N.","Ohtsubo Y.","Waniguchi K.","Shoji S."],"citationCrossReferences":[{"database":"PubMed","id":"15117453"},{"database":"DOI","id":"10.1089/088922204322996536"}],"title":"Zn2+ binding to cysteine-rich domain of extracellular human immunodeficiency virus type 1 Tat protein is associated with Tat protein-induced apoptosis.","publicationDate":"2004","journal":"AIDS Res. Hum. Retroviruses","firstPage":"297","lastPage":"304","volume":"20"},"referencePositions":["CYS-RICH REGION","ZINC-BINDING"]},{"citation":{"id":"15713622","citationType":"journal article","authors":["Kumar P.P.","Purbey P.K.","Ravi D.S.","Mitra D.","Galande S."],"citationCrossReferences":[{"database":"PubMed","id":"15713622"},{"database":"DOI","id":"10.1128/mcb.25.5.1620-1633.2005"}],"title":"Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells.","publicationDate":"2005","journal":"Mol. Cell. Biol.","firstPage":"1620","lastPage":"1633","volume":"25"},"referencePositions":["FUNCTION","INTERACTION WITH HUMAN SATB1"]},{"citation":{"id":"15719057","citationType":"journal article","authors":["Pagans S.","Pedal A.","North B.J.","Kaehlcke K.","Marshall B.L.","Dorr A.","Hetzer-Egger C.","Henklein P.","Frye R.","McBurney M.W.","Hruby H.","Jung M.","Verdin E.","Ott M."],"citationCrossReferences":[{"database":"PubMed","id":"15719057"},{"database":"DOI","id":"10.1371/journal.pbio.0030041"}],"title":"SIRT1 regulates HIV transcription via Tat deacetylation.","publicationDate":"2005","journal":"PLoS Biol.","firstPage":"210","lastPage":"220","volume":"3"},"referencePositions":["INTERACTION WITH HUMAN SIRT1","DEACETYLATION AT LYS-50 BY SIRT1"]},{"citation":{"id":"16001085","citationType":"journal article","authors":["Col E.","Caron C.","Chable-Bessia C.","Legube G.","Gazzeri S.","Komatsu Y.","Yoshida M.","Benkirane M.","Trouche D.","Khochbin S."],"citationCrossReferences":[{"database":"PubMed","id":"16001085"},{"database":"DOI","id":"10.1038/sj.emboj.7600734"}],"title":"HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses.","publicationDate":"2005","journal":"EMBO J.","firstPage":"2634","lastPage":"2645","volume":"24"},"referencePositions":["INTERACTION WITH HUMAN KAT5"],"referenceComments":[{"value":"Clone pNL4-3","type":"STRAIN"}]},{"citation":{"id":"15719058","citationType":"journal article","authors":["Raha T.","Cheng S.W.G.","Green M.R."],"citationCrossReferences":[{"database":"PubMed","id":"15719058"},{"database":"DOI","id":"10.1371/journal.pbio.0030044"}],"title":"HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs.","publicationDate":"2005","journal":"PLoS Biol.","firstPage":"221","lastPage":"230","volume":"3"},"referencePositions":["FUNCTION","INTERACTION WITH HUMAN TBP"]},{"citation":{"id":"16807369","citationType":"journal article","authors":["Rumbaugh J.","Turchan-Cholewo J.","Galey D.","St Hillaire C.","Anderson C.","Conant K.","Nath A."],"citationCrossReferences":[{"database":"PubMed","id":"16807369"},{"database":"DOI","id":"10.1096/fj.05-5619fje"}],"title":"Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism.","publicationDate":"2006","journal":"FASEB J.","firstPage":"1736","lastPage":"1738","volume":"20"},"referencePositions":["INTERACTION WITH HUMAN MMP1"]},{"citation":{"id":"16920714","citationType":"journal article","authors":["Gee K.","Angel J.B.","Ma W.","Mishra S.","Gajanayaka N.","Parato K.","Kumar A."],"citationCrossReferences":[{"database":"PubMed","id":"16920714"},{"database":"DOI","id":"10.1074/jbc.m512109200"}],"title":"Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells.","publicationDate":"2006","journal":"J. Biol. Chem.","firstPage":"31647","lastPage":"31658","volume":"281"},"referencePositions":["FUNCTION"]},{"citation":{"id":"16046164","citationType":"journal article","authors":["Hetzer C.","Dormeyer W.","Schnolzer M.","Ott M."],"citationCrossReferences":[{"database":"PubMed","id":"16046164"},{"database":"DOI","id":"10.1016/j.micinf.2005.06.003"}],"title":"Decoding Tat: the biology of HIV Tat posttranslational modifications.","publicationDate":"2005","journal":"Microbes Infect.","firstPage":"1364","lastPage":"1369","volume":"7"},"referencePositions":["REVIEW","ALTERNATIVE SPLICING"]},{"citation":{"id":"16146763","citationType":"journal article","authors":["Peruzzi F."],"citationCrossReferences":[{"database":"PubMed","id":"16146763"},{"database":"DOI","id":"10.2741/1829"}],"title":"The multiple functions of HIV-1 Tat: proliferation versus apoptosis.","publicationDate":"2006","journal":"Front. Biosci.","firstPage":"708","lastPage":"717","volume":"11"},"referencePositions":["REVIEW"]},{"citation":{"id":"16697675","citationType":"journal article","authors":["King J.E.","Eugenin E.A.","Buckner C.M.","Berman J.W."],"citationCrossReferences":[{"database":"PubMed","id":"16697675"},{"database":"DOI","id":"10.1016/j.micinf.2005.11.014"}],"title":"HIV tat and neurotoxicity.","publicationDate":"2006","journal":"Microbes Infect.","firstPage":"1347","lastPage":"1357","volume":"8"},"referencePositions":["REVIEW"]},{"citation":{"id":"19671151","citationType":"journal article","authors":["Charnay N.","Ivanyi-Nagy R.","Soto-Rifo R.","Ohlmann T.","Lopez-Lastra M.","Darlix J.L."],"citationCrossReferences":[{"database":"PubMed","id":"19671151"},{"database":"DOI","id":"10.1186/1742-4690-6-74"}],"title":"Mechanism of HIV-1 Tat RNA translation and its activation by the Tat protein.","publicationDate":"2009","journal":"Retrovirology","firstPage":"74","lastPage":"74","volume":"6"},"referencePositions":["FUNCTION"]},{"citation":{"id":"11931765","citationType":"journal article","authors":["Mujtaba S.","He Y.","Zeng L.","Farooq A.","Carlson J.E.","Ott M.","Verdin E.","Zhou M.-M."],"citationCrossReferences":[{"database":"PubMed","id":"11931765"},{"database":"DOI","id":"10.1016/s1097-2765(02)00483-5"}],"title":"Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain.","publicationDate":"2002","journal":"Mol. Cell","firstPage":"575","lastPage":"586","volume":"9"},"referencePositions":["STRUCTURE BY NMR OF 46-55 IN COMPLEX WITH PCAF BROMODOMAIN"]},{"citation":{"id":"11098404","citationType":"journal article","authors":["Peloponese J.M. Jr.","Gregoire C.","Opi S.","Esquieu D.","Sturgis J.","Lebrun E.","Meurs E.","Collette Y.","Olive D.","Aubertin A.M.","Witvrow M.","Pannecouque C.","De Clercq E.","Bailly C.","Lebreton J.","Loret E.P."],"citationCrossReferences":[{"database":"PubMed","id":"11098404"},{"database":"DOI","id":"10.1016/s0764-4469(00)01228-2"}],"title":"1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein.","publicationDate":"2000","journal":"C. R. Acad. Sci. III, Sci. Vie","firstPage":"883","lastPage":"894","volume":"323"},"referencePositions":["STRUCTURE BY NMR"]}],"uniProtKBCrossReferences":[{"database":"EMBL","id":"K02013","properties":[{"key":"ProteinId","value":"AAB59745.1"},{"key":"Status","value":"-"},{"key":"MoleculeType","value":"Genomic_RNA"}]},{"database":"EMBL","id":"M19921","properties":[{"key":"ProteinId","value":"AAA44985.1"},{"key":"Status","value":"-"},{"key":"MoleculeType","value":"Genomic_RNA"}]},{"database":"PIR","id":"A25700","properties":[{"key":"EntryName","value":"A25700"}]},{"database":"PDB","id":"1JFW","properties":[{"key":"Method","value":"NMR"},{"key":"Resolution","value":"-"},{"key":"Chains","value":"A=1-86"}]},{"database":"PDB","id":"1JM4","properties":[{"key":"Method","value":"NMR"},{"key":"Resolution","value":"-"},{"key":"Chains","value":"A=46-55"}]},{"database":"PDBsum","id":"1JFW","properties":[{"key":"Description","value":"-"}]},{"database":"PDBsum","id":"1JM4","properties":[{"key":"Description","value":"-"}]},{"database":"SMR","id":"P04610","properties":[{"key":"Description","value":"-"}]},{"database":"IntAct","id":"P04610","properties":[{"key":"Interactions","value":"8"}]},{"database":"MINT","id":"P04610","properties":[{"key":"Description","value":"-"}]},{"database":"iPTMnet","id":"P04610","properties":[{"key":"Description","value":"-"}]},{"database":"EvolutionaryTrace","id":"P04610","properties":[{"key":"Description","value":"-"}]},{"database":"Proteomes","id":"UP000007692","properties":[{"key":"Component","value":"Genome"}]},{"database":"GO","id":"GO:0005576","properties":[{"key":"GoTerm","value":"C:extracellular region"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-SubCell"}]},{"database":"GO","id":"GO:0030430","properties":[{"key":"GoTerm","value":"C:host cell cytoplasm"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-SubCell"}]},{"database":"GO","id":"GO:0044196","properties":[{"key":"GoTerm","value":"C:host cell nucleolus"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-SubCell"}]},{"database":"GO","id":"GO:0042805","properties":[{"key":"GoTerm","value":"F:actinin binding"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0030332","properties":[{"key":"GoTerm","value":"F:cyclin binding"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0046872","properties":[{"key":"GoTerm","value":"F:metal ion binding"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0019904","properties":[{"key":"GoTerm","value":"F:protein domain specific binding"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0004865","properties":[{"key":"GoTerm","value":"F:protein serine/threonine phosphatase inhibitor activity"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-KW"}]},{"database":"GO","id":"GO:0001069","properties":[{"key":"GoTerm","value":"F:regulatory region RNA binding"},{"key":"GoEvidenceType","value":"IPI:DisProt"}],"evidences":[{"evidenceCode":"ECO:0000353","source":"PubMed","id":"10206951"}]},{"database":"GO","id":"GO:0001070","properties":[{"key":"GoTerm","value":"F:RNA-binding transcription regulator activity"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:1990970","properties":[{"key":"GoTerm","value":"F:trans-activation response element binding"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0006351","properties":[{"key":"GoTerm","value":"P:DNA-templated transcription"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0060081","properties":[{"key":"GoTerm","value":"P:membrane hyperpolarization"},{"key":"GoEvidenceType","value":"IDA:CACAO"}],"evidences":[{"evidenceCode":"ECO:0000314","source":"PubMed","id":"17202348"}]},{"database":"GO","id":"GO:0039525","properties":[{"key":"GoTerm","value":"P:modulation by virus of host chromatin organization"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:1901856","properties":[{"key":"GoTerm","value":"P:negative regulation of cellular respiration"},{"key":"GoEvidenceType","value":"IDA:CACAO"}],"evidences":[{"evidenceCode":"ECO:0000314","source":"PubMed","id":"17202348"}]},{"database":"GO","id":"GO:0010801","properties":[{"key":"GoTerm","value":"P:negative regulation of peptidyl-threonine phosphorylation"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0051092","properties":[{"key":"GoTerm","value":"P:positive regulation of NF-kappaB transcription factor activity"},{"key":"GoEvidenceType","value":"IDA:CACAO"}],"evidences":[{"evidenceCode":"ECO:0000314","source":"PubMed","id":"10400814"}]},{"database":"GO","id":"GO:1900182","properties":[{"key":"GoTerm","value":"P:positive regulation of protein localization to nucleus"},{"key":"GoEvidenceType","value":"IDA:CACAO"}],"evidences":[{"evidenceCode":"ECO:0000314","source":"PubMed","id":"22219277"}]},{"database":"GO","id":"GO:0032968","properties":[{"key":"GoTerm","value":"P:positive regulation of transcription elongation by RNA polymerase II"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0050434","properties":[{"key":"GoTerm","value":"P:positive regulation of viral transcription"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0039606","properties":[{"key":"GoTerm","value":"P:suppression by virus of host translation initiation"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-KW"}]},{"database":"GO","id":"GO:0039502","properties":[{"key":"GoTerm","value":"P:suppression by virus of host type I interferon-mediated signaling pathway"},{"key":"GoEvidenceType","value":"IEA:UniProtKB-UniRule"}]},{"database":"GO","id":"GO:0019080","properties":[{"key":"GoTerm","value":"P:viral gene expression"},{"key":"GoEvidenceType","value":"IEP:DisProt"}],"evidences":[{"evidenceCode":"ECO:0000270","source":"PubMed","id":"10206951"},{"evidenceCode":"ECO:0000270","source":"PubMed","id":"21752913"}]},{"database":"Gene3D","id":"4.10.20.10","properties":[{"key":"EntryName","value":"Tat domain"},{"key":"MatchStatus","value":"1"}]},{"database":"HAMAP","id":"MF_04079","properties":[{"key":"EntryName","value":"HIV_TAT"},{"key":"MatchStatus","value":"1"}]},{"database":"InterPro","id":"IPR001831","properties":[{"key":"EntryName","value":"IV_Tat"}]},{"database":"InterPro","id":"IPR036963","properties":[{"key":"EntryName","value":"Tat_dom_sf"}]},{"database":"Pfam","id":"PF00539","properties":[{"key":"EntryName","value":"Tat"},{"key":"MatchStatus","value":"1"}]},{"database":"PRINTS","id":"PR00055","properties":[{"key":"EntryName","value":"HIVTATDOMAIN"}]}],"sequence":{"value":"MEPVDPRLEPWKHPGSQPKTACTTCYCKKCCFHCQVCFTTKALGISYGRKKRRQRRRPPQGSQTHQVSLSKQPTSQPRGDPTGPKE","length":86,"molWeight":9769,"crc64":"9B1B4A915FAF8A14","md5":"2E64A1348CFC636018A2F4BF1EDA43A7"},"extraAttributes":{"countByCommentType":{"FUNCTION":2,"SUBUNIT":1,"INTERACTION":2,"SUBCELLULAR LOCATION":1,"ALTERNATIVE PRODUCTS":2,"DOMAIN":4,"PTM":4,"MISCELLANEOUS":4,"SIMILARITY":1},"countByFeatureType":{"Chain":1,"Region":7,"Motif":2,"Compositional bias":1,"Binding site":7,"Site":1,"Modified residue":5,"Cross-link":1,"Alternative sequence":1,"Natural variant":5,"Mutagenesis":3,"Beta strand":8,"Turn":2},"uniParcId":"UPI0000111F40"}}